RVU — Ryvu Therapeutics SA Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapSucker Stock

Annual balance sheet for Ryvu Therapeutics SA, fiscal year end - December 31st, PLN millions except per share, conversion factor applied.

	C2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	88.2	345	234	226	108
Net Total Accounts Receivable
Net Total Receivables	11.7	16.9	32.8	35.8	20.1
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	104	368	278	272	139
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	91.2	82.2	77.6	72.7	70
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	229	475	403	379	224
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	36.2	44.8	69.7	108	61.6
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Funded Status
Total Liabilities	67.5	132	144	235	171
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	161	343	260	144	53.8
Total Liabilities & Shareholders' Equity	229	475	403	379	224
Total Common Shares Outstanding